Pathogenesis and pathophysiology of yellow fever
- PMID: 14689698
- DOI: 10.1016/s0065-3527(03)60009-6
Pathogenesis and pathophysiology of yellow fever
Abstract
It will be apparent to the reader that there is much to learn about the pathogenesis of YF. The role of specific genes and molecular determinants of neurotropism and viscerotropism has been defined only partially. The availability of infectious clones and a small animal (hamster) model should allow dissection of virulence factors, which can then be tested in the more difficult monkey model. The marked differences between wild-type YF strains should be evaluated by evaluating the relationships between virulence and genome sequence. The role of cytokine dysregulation and endothelial injury in YF will be elucidated as access to patients and of patients to more sophisticated medical care improves. The number of cases of YF in unvaccinated travelers hospitalized after return from the tropics has unfortunately increased, but such cases afford unique opportunities to study the pathogenesis of renal failure, coagulopathy, vascular instability, and shock, as well as new treatment modalities. At the cellular level, there are also important opportunities for research on YF virus-cell receptor interactions, the control of apoptotic cell death, and the predilection for cells of the midzone of the liver lobule. The role of dendritic cells in the early stage of YF infection is deserving of study. Finally, the role of the immune response to infection, particularly cellular immunity, is poorly characterized, and the suggestion that immune clearance may aggravate the condition of the host during the period of intoxication should be evaluated in appropriate animal models.
Similar articles
-
Yellow fever: the recurring plague.Crit Rev Clin Lab Sci. 2004;41(4):391-427. doi: 10.1080/10408360490497474. Crit Rev Clin Lab Sci. 2004. PMID: 15487593 Review.
-
Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil.Vaccine. 2006 Apr 5;24(15):2803-9. doi: 10.1016/j.vaccine.2006.01.009. Epub 2006 Jan 18. Vaccine. 2006. PMID: 16464518
-
Antibody-mediated early death in vivo after infection with yellow fever virus.J Gen Virol. 1986 Nov;67 ( Pt 11):2539-42. doi: 10.1099/0022-1317-67-11-2539. J Gen Virol. 1986. PMID: 3783130
-
Vaccination with Replication Deficient Adenovectors Encoding YF-17D Antigens Induces Long-Lasting Protection from Severe Yellow Fever Virus Infection in Mice.PLoS Negl Trop Dis. 2016 Feb 17;10(2):e0004464. doi: 10.1371/journal.pntd.0004464. eCollection 2016 Feb. PLoS Negl Trop Dis. 2016. PMID: 26886513 Free PMC article.
-
Treatment of yellow fever.Antiviral Res. 2008 Apr;78(1):116-24. doi: 10.1016/j.antiviral.2007.10.009. Epub 2007 Nov 20. Antiviral Res. 2008. PMID: 18061688 Review.
Cited by
-
Flavivirus Receptors: Diversity, Identity, and Cell Entry.Front Immunol. 2018 Sep 26;9:2180. doi: 10.3389/fimmu.2018.02180. eCollection 2018. Front Immunol. 2018. PMID: 30319635 Free PMC article. Review.
-
Flavivirus NS1 Triggers Tissue-Specific Vascular Endothelial Dysfunction Reflecting Disease Tropism.Cell Rep. 2019 Feb 5;26(6):1598-1613.e8. doi: 10.1016/j.celrep.2019.01.036. Cell Rep. 2019. PMID: 30726741 Free PMC article.
-
Inhibitory effect of essential oils obtained from plants grown in Colombia on yellow fever virus replication in vitro.Ann Clin Microbiol Antimicrob. 2009 Mar 6;8:8. doi: 10.1186/1476-0711-8-8. Ann Clin Microbiol Antimicrob. 2009. PMID: 19267922 Free PMC article.
-
Perspective of Quilombola Communities in Brazil on a Yellow Fever Outbreak and Vaccination.Am J Trop Med Hyg. 2025 Apr 1;112(6):1302-1312. doi: 10.4269/ajtmh.24-0519. Print 2025 Jun 4. Am J Trop Med Hyg. 2025. PMID: 40168978
-
Viral hijacking of hnRNPH1 unveils a G-quadruplex-driven mechanism of stress control.Cell Host Microbe. 2024 Sep 11;32(9):1579-1593.e8. doi: 10.1016/j.chom.2024.07.006. Epub 2024 Aug 1. Cell Host Microbe. 2024. PMID: 39094585 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources